This webinar will discuss the FDA requirements and guidelines for investigating Out-of-trend (OOT) results in the pharmaceutical laboratory. It will also cover FDA-compliant documentation of OOT, failure investigations, root causes, and CAPA.
FDA's guidance on OOS test results requires failure investigations and other steps for Out-of-Specification (OOS) and Out-of-trend (OOT) results. While most companies are familiar with and have procedures for OOS results, this is not the case for OOT situations. The guide states: "Although the subject of this document is OOS results, much of the guidance may be useful for examining results that are out of trend". Managing OOT results also helps to avoid time-consuming OOS results. The industry is unsure how to interpret and implement the FDA guidance.
This session will equip you with the knowledge and comprehensive understanding of FDA requirements for Out-of-Trend Results in pharmaceutical quality control.
FDA's guidance on OOS test results requires failure investigations and other steps for Out-of-Specification (OOS) and Out-of-trend (OOT) results. While most companies are familiar with and have procedures for OOS results, this is not the case for OOT situations. The guide states: "Although the subject of this document is OOS results, much of the guidance may be useful for examining results that are out of trend". Managing OOT results also helps to avoid time-consuming OOS results. The industry is unsure how to interpret and implement the FDA guidance.
This session will equip you with the knowledge and comprehensive understanding of FDA requirements for Out-of-Trend Results in pharmaceutical quality control.
Kelly Thomas
Ms. Thomas has over two decades of cGMP hands-on industry experience in both pharmaceutical and medical device manufacturing operations. Her experience covers all Quality Systems; as well as, all areas of validation; including, process/product validation, facilities validation, CSV and 21 CFR Part 11, test method validation, equipment/automated processes and cleaning validation.Utilizing strategic thinking, risk based approaches, and Lean principles, she has demonstrated success in steering and managing complex projects within the pharmaceutical and medical device industries.
2-Hour Virtual Seminar on DeepSeek vs ChatGPT AI for CPAs a…
Construction Lending And Real Credit Administration: Evalua…
How the OBBB Act will Impact Immigration Enforcement! Preve…
Sunshine Act Reporting - Clarification for Clinical Research
FDA Regulation of Artificial Intelligence/ Machine Learning
2-Hour Virtual Seminar on Outlook - Timesaving Tips and Tri…
Leadership Upskilling: Don’t Just Manage; Lead with Influen…
Aligning Your HR Strategy with Your Business Strategy: A Ro…
H-1B Visa Updates and Employer Strategies for 2026
AI for Excel Professionals: Enhancing Productivity with Cha…
HIPAA 2025 – Major Changes, Latest Rulings & Guidance
Understanding Accounting for non - Accounting professionals
Dealing With Difficult People: At Work & In Life
2-Hour Virtual Seminar on How to Conduct an Internal Harass…
Project Management for Non-Project Managers - Scheduling yo…
ChatGPT and Project Management: Leveraging AI for Project M…
Language is Code - Intro to AI - Generative AI - ChatGPT an…
Copilot and HR: An Introduction for HR Professionals
Harassment, Bullying, Gossip, Confrontational and Disruptiv…
Excel Power Skills: Master Functions, Formulas, and Macros …
Project Management for administrative professionals